Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 4 » Issue 1
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (4041)
- Volume 19, 2023 (184)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Archive: Volume 4, 2008
Erratum
Shapiro MA, Chang YL, Munson SK, et al.
Neuropsychiatric Disease and Treatment 2008, 4:319-319
Published Date: 8 February 2008
Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder
A Carlo Altamura, Jose M Goikolea
Neuropsychiatric Disease and Treatment 2008, 4:311-317
Published Date: 8 February 2008
First true initial ictal SPECT in partial epilepsy verified by electroencephalography
Jesús Pastor, Luis Domínguez-Gadea, Rafael G Sola, Virgilio Hernando, María Luisa Meilán, et al
Neuropsychiatric Disease and Treatment 2008, 4:305-309
Published Date: 8 February 2008
Normal pressure hydrocephalus co-existing with a second dementia disorder
Joseph Alisky
Neuropsychiatric Disease and Treatment 2008, 4:301-304
Published Date: 8 February 2008
Effects of milnacipran on binge eating – a pilot study
Shun’ichi Noma, Teruhisa Uwatoko, Haruka Yamamoto, Takuji Hayashi
Neuropsychiatric Disease and Treatment 2008, 4:295-300
Published Date: 8 February 2008
Serum substance P levels in patients with chronic schizophrenia treated with typical or atypical antipsychotics
Takahiko Nagamine
Neuropsychiatric Disease and Treatment 2008, 4:289-294
Published Date: 8 February 2008
White versus gray matter function as seen on neuropsychological testing following bone marrow transplant for acute leukemia in childhood
Fiona S Anderson, Alicia S Kunin-Batson, Joanna L Perkins, K Scott Baker
Neuropsychiatric Disease and Treatment 2008, 4:283-288
Published Date: 8 February 2008
Preliminary effects of pagoclone, a partial GABAA agonist, on neuropsychological performance
Angela F Caveney, Bruno Giordani, George M Haig
Neuropsychiatric Disease and Treatment 2008, 4:277-282
Published Date: 8 February 2008
Association analysis between variants of the interleukin-1β and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression
André Tadic, Dan Rujescu, Matthias J Müller, Ralf Kohnen, Hans H. Stassen, et al
Neuropsychiatric Disease and Treatment 2008, 4:269-276
Published Date: 8 February 2008
The classification of chronic daily headache in French children and adolescents: A comparison between the second edition of the International Classification of Headache Disorders and Silberstein-Lipton criteria
Jean-Christophe Cuvellier, Frédéric Couttenier, Stéphane Auvin, Louis Vallée
Neuropsychiatric Disease and Treatment 2008, 4:263-267
Published Date: 8 February 2008
Prevalence of eating disorders and eating attacks in narcolepsy
Norbert Dahmen, Julia Becht, Alice Engel, Monika Thommes, Peter Tonn
Neuropsychiatric Disease and Treatment 2008, 4:257-261
Published Date: 8 February 2008
Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?
Maurizio Pompili, Marco Innamorati, Michele Raja, Ilaria Falcone, Giuseppe Ducci, et al
Neuropsychiatric Disease and Treatment 2008, 4:247-255
Published Date: 8 February 2008
Functional MRI evidence for language plasticity in adult epileptic patients: Preliminary results
Emilie Cousin, Monica Baciu, Cédric Pichat1, Philippe Kahane, Jean-François Le Bas
Neuropsychiatric Disease and Treatment 2008, 4:235-246
Published Date: 8 February 2008
Anticonvulsant treatments of dysphoric mania: a trial of gabapentin, lamotrigine and carbamazepine in Iran
Naghmeh Mokhber, Carol J Lane, Mohamad R Azarpazhooh, Elham Salari, Reza Fayazi, et al
Neuropsychiatric Disease and Treatment 2008, 4:227-234
Published Date: 8 February 2008
Relationship between obesity and antipsychotic drug use in the adult population: A longitudinal, retrospective claim database study in Primary Care settings
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Javier Rejas-Gutiérrez, Milagrosa Blanca-Tamayo
Neuropsychiatric Disease and Treatment 2008, 4:219-226
Published Date: 8 February 2008
Neurosteroids block the increase in intracellular calcium level induced by Alzheimer’s β-amyloid protein in long-term cultured rat hippocampal neurons
Midori Kato-Negishi, Masahiro Kawahara
Neuropsychiatric Disease and Treatment 2008, 4:209-218
Published Date: 8 February 2008
Risperidone treatment for ADHD in children and adolescents with bipolar disorder
Joseph Biederman, Paul Hammerness, Robert Doyle, Gagan Joshi, Megan Aleardi, Eric Mick
Neuropsychiatric Disease and Treatment 2008, 4:203-207
Published Date: 8 February 2008
The relationship between early life stress and microstructural integrity of the corpus callosum in a non-clinical population
Robert Paul, Lorrie Henry, Stuart M Grieve, Thomas J Guilmette, Raymond Niaura, et al
Neuropsychiatric Disease and Treatment 2008, 4:193-201
Published Date: 8 February 2008
Resting and reactive frontal brain electrical activity (EEG) among a non-clinical sample of socially anxious adults: Does concurrent depressive mood matter?
Elliott A Beaton, Louis A Schmidt, Andrea R Ashbaugh, Diane L Santesso, Martin M Antony, Randi E McCabe
Neuropsychiatric Disease and Treatment 2008, 4:187-192
Published Date: 8 February 2008
Treatment of adult ADHD: Is current knowledge useful to clinicians?
Terje Torgersen, Bjørn Gjervan, Kirsten Rasmussen
Neuropsychiatric Disease and Treatment 2008, 4:177-186
Published Date: 8 February 2008
Adenylyl cyclase-cyclicAMP signaling in mood disorders: Role of the crucial phosphorylating enzyme protein kinase A
Yogesh Dwivedi, Ghanshyam N Pandey
Neuropsychiatric Disease and Treatment 2008, 4:161-176
Published Date: 8 February 2008
Gait analysis in demented subjects: Interests and perspectives
Olivier Beauchet, Gilles Allali, Gilles Berrut, Caroline Hommet, Véronique Dubost, Frédéric Assal
Neuropsychiatric Disease and Treatment 2008, 4:155-160
Published Date: 8 February 2008
Epidemiology and treatment of post-stroke depression
Stefano Paolucci
Neuropsychiatric Disease and Treatment 2008, 4:145-154
Published Date: 8 February 2008
Social anxiety disorder: A review of environmental risk factors
Christina A Brook, Louis A Schmidt
Neuropsychiatric Disease and Treatment 2008, 4:123-143
Published Date: 8 February 2008
Treatment of adults with attention-deficit/hyperactivity disorder
Dusan Kolar, Amanda Keller, Maria Golfinopoulos, Lucy Cumyn, Cassidy Syer, Lily Hechtman
Neuropsychiatric Disease and Treatment 2008, 4:107-121
Published Date: 8 February 2008
Pharmacological management of panic disorder
Carlo Marchesi
Neuropsychiatric Disease and Treatment 2008, 4:93-106
Published Date: 8 February 2008
Depression in Parkinson’s disease: Health risks, etiology, and treatment options
Pasquale G Frisina, Joan C Borod, Nancy S Foldi, Harriet R Tenenbaum
Neuropsychiatric Disease and Treatment 2008, 4:81-91
Published Date: 8 February 2008
A review of ramelteon in the treatment of sleep disorders
David N Neubauer
Neuropsychiatric Disease and Treatment 2008, 4:69-79
Published Date: 8 February 2008
Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
Jeffrey R Bishop, Mani N Pavuluri
Neuropsychiatric Disease and Treatment 2008, 4:55-68
Published Date: 8 February 2008
Review of frovatriptan in the treatment of migraine
Leslie Kelman
Neuropsychiatric Disease and Treatment 2008, 4:49-54
Published Date: 8 February 2008
Optimizing levodopa therapy for Parkinson’s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective
David J Brooks
Neuropsychiatric Disease and Treatment 2008, 4:39-47
Published Date: 8 February 2008
Monotherapy for partial epilepsy: focus on levetiracetam
Antonio Gambardella, Angelo Labate, Eleonora Colosimo, Roberta Ambrosio, Aldo Quattrone
Neuropsychiatric Disease and Treatment 2008, 4:33-38
Published Date: 8 February 2008
Quetiapine monotherapy for bipolar depression
Michael E Thase
Neuropsychiatric Disease and Treatment 2008, 4:21-31
Published Date: 8 February 2008
Rasagiline in treatment of Parkinson’s disease
Lakshmi Nayak, Claire Henchcliffe
Neuropsychiatric Disease and Treatment 2008, 4:11-20
Published Date: 8 February 2008
COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features
Angelo Antonini, Giovanni Abbruzzese, Paolo Barone, Ubaldo Bonuccelli, Leonardo Lopiano, et al
Neuropsychiatric Disease and Treatment 2008, 4:1-9
Published Date: 8 February 2008
Editorial Foreword: Drugs for Parkinson’s disease: Levodopa is still the gold standard || FREE PAPER ||
Roger M Pinder
Neuropsychiatric Disease and Treatment 2008, 4:0-0
Published Date: 8 February 2008